Zydus Lifesciences Stock Forecast

Stock Price Forecast

According to 30 analysts polled by S&P Global, Zydus Lifesciences stock has a consensus rating of "Hold" and an average price target of ₹1,067. The average 1-year stock price forecast is 0.40% lower than the current stock price, while the lowest is ₹800.00 (-25.29%) and the highest is ₹1,457 (+36.07%).

Price Target: ₹1,067 (-0.40%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	₹800.00	₹1,067	₹1,065	₹1,457
Change	-25.29%	-0.40%	-0.54%	+36.07%

* Price targets were last updated on May 22, 2026.

Analyst Ratings

The average analyst rating for Zydus Lifesciences stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	5	6	5	4	6	6
Buy	8	8	8	8	9	9
Hold	10	9	10	10	10	10
Sell	4	4	4	4	2	2
Strong Sell	3	3	3	3	3	3
Total	30	30	30	29	30	30

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jenny Ping Citi	Citi	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Jun 5, 2026
Bansi Desai J.P. Morgan	J.P. Morgan	Hold Maintains ₹1,050	Hold	Maintains	₹1,050	-1.94%	May 22, 2026
Unknown Analyst Prabhudas Lilladher No rating	Prabhudas Lilladher	Buy Maintains ₹1,020	Buy	Maintains	₹1,020	-4.74%	Feb 12, 2026

Financial Forecast

Revenue This Year

309.95B

from 271.48B

14.17%

from 271.48B

Revenue Next Year

334.47B

from 309.95B

7.91%

from 309.95B

EPS This Year

41.19

from 54.00

-23.73%

from 54.00

EPS Next Year

46.66

from 41.19

13.29%

from 41.19

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	151.10B	172.37B	195.47B	232.42B	271.48B	309.95B
Revenue Growth	4.90%	14.08%	13.40%	18.90%	16.81%	14.17%
Gross Profit	94.24B	107.67B	131.54B	167.03B	198.56B	220.36B
Gross Margin	62.37%	62.46%	67.29%	71.87%	73.14%	71.09%
Operating Income	24.74B	28.53B	45.39B	59.60B	57.87B	55.07B
Net Income	44.87B	19.60B	38.60B	45.26B	50.40B	42.46B
EPS	-	-	-	-	54.00	41.19
EPS Growth	-	-	-	-	15.73%	-23.73%
Forward PE	16.57	21.39	28.46	19.01	20.54	26.00
Dividend / Share	2.50	6.00	3.00	11.00	1.00	6.66
Dividend Growth	-	140.00%	-50.00%	266.67%	-90.91%	565.59%
Free Cash Flow	7.54B	10.61B	16.06B	28.38B	13.31B	41.27B
No. Analysts	-	-	-	-	-	23

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue	2027	2028	2029
High	343.2B
Avg	310.0B
Low	297.5B

Revenue Growth

Revenue Growth	2027	2028	2029
High	26.4%
Avg	14.2%
Low	9.6%

EPS Forecast

EPS	2027	2028	2029
High	46.40
Avg	41.19
Low	35.30

EPS Growth

EPS Growth	2027	2028	2029
High	-14.1%
Avg	-23.7%
Low	-34.6%